| - GRCh37:
- Chr11:111715425
- GRCh38:
- Chr11:111844702
| ALG9 | Y110C, Y135C, Y306C | Gillessen-Kaesbach-Nishimura syndrome, ALG9 congenital disorder of glycosylation | Uncertain significance (Jun 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:111741109
- GRCh38:
- Chr11:111870386
| ALG9 | | ALG9 congenital disorder of glycosylation, Gillessen-Kaesbach-Nishimura syndrome, ALG9 congenital disorder of glycosylation
| Likely benign (Oct 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:111724361
- GRCh38:
- Chr11:111853638
| ALG9 | | Gillessen-Kaesbach-Nishimura syndrome, ALG9 congenital disorder of glycosylation, ALG9 congenital disorder of glycosylation
| Likely benign (Oct 31, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:111741107
- GRCh38:
- Chr11:111870384
| ALG9 | | ALG9 congenital disorder of glycosylation, Gillessen-Kaesbach-Nishimura syndrome, ALG9 congenital disorder of glycosylation
| Benign (Oct 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:111728461
- GRCh38:
- Chr11:111857738
| ALG9 | | ALG9 congenital disorder of glycosylation, Gillessen-Kaesbach-Nishimura syndrome, ALG9 congenital disorder of glycosylation
| Likely pathogenic (Jan 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:111706988
- GRCh38:
- Chr11:111836265
| ALG9 | F282Y, F298Y, F323Y, F330Y, F453Y, F494Y, F501Y | ALG9 congenital disorder of glycosylation, Gillessen-Kaesbach-Nishimura syndrome, ALG9 congenital disorder of glycosylation
| Uncertain significance (Jul 21, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:111728324
- GRCh38:
- Chr11:111857601
| ALG9 | | Gillessen-Kaesbach-Nishimura syndrome, ALG9 congenital disorder of glycosylation | Likely pathogenic (Jun 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:111739318
- GRCh38:
- Chr11:111868595
| ALG9 | | ALG9 congenital disorder of glycosylation, ALG9 congenital disorder of glycosylation, Gillessen-Kaesbach-Nishimura syndrome
| Likely benign (Oct 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:111708982
- GRCh38:
- Chr11:111838259
| ALG9 | | ALG9 congenital disorder of glycosylation, Gillessen-Kaesbach-Nishimura syndrome, ALG9 congenital disorder of glycosylation
| Likely benign (Jul 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:111711385
- GRCh38:
- Chr11:111840662
| ALG9 | A348V, A193V, A389V, A177V, A218V | Inborn genetic diseases, ALG9 congenital disorder of glycosylation, ALG9 congenital disorder of glycosylation, Gillessen-Kaesbach-Nishimura syndrome | Uncertain significance (Sep 1, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:111724420
- GRCh38:
- Chr11:111853697
| ALG9 | R247S, R51S, R76S | ALG9 congenital disorder of glycosylation, ALG9-related condition, ALG9 congenital disorder of glycosylation, Gillessen-Kaesbach-Nishimura syndrome, not provided | Uncertain significance (Mar 14, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:111731298
- GRCh38:
- Chr11:111860575
| ALG9 | | not specified, not provided, Gillessen-Kaesbach-Nishimura syndrome, ALG9 congenital disorder of glycosylation, ALG9 congenital disorder of glycosylation | Likely benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:111715397
- GRCh38:
- Chr11:111844674
| ALG9 | | ALG9 congenital disorder of glycosylation, Gillessen-Kaesbach-Nishimura syndrome, not provided, not specified, ALG9 congenital disorder of glycosylation | Likely benign (Oct 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:111657184
- GRCh38:
- Chr11:111786460
| ALG9 | | ALG9 congenital disorder of glycosylation, Gillessen-Kaesbach-Nishimura syndrome, ALG9 congenital disorder of glycosylation, not provided | Benign/Likely benign (Oct 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:111711402
- GRCh38:
- Chr11:111840679
| ALG9 | | not specified, ALG9 congenital disorder of glycosylation, Gillessen-Kaesbach-Nishimura syndrome
| Likely benign (Jan 6, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:111707031
- GRCh38:
- Chr11:111836308
| ALG9 | | ALG9 congenital disorder of glycosylation, Gillessen-Kaesbach-Nishimura syndrome, not specified
| Benign (Oct 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:111724133
- GRCh38:
- Chr11:111853410
| ALG9 | V289I, V93I, V118I | not specified, ALG9 congenital disorder of glycosylation, Gillessen-Kaesbach-Nishimura syndrome
| Benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:111706952
- GRCh38:
- Chr11:111836229
| ALG9 | P513L, P342L, P465L, P506L, P294L, P310L, P335L | not provided, ALG9 congenital disorder of glycosylation, ALG9 congenital disorder of glycosylation, Gillessen-Kaesbach-Nishimura syndrome, not specified | Benign/Likely benign (Oct 1, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:111711376
- GRCh38:
- Chr11:111840653
| ALG9 | | Gillessen-Kaesbach-Nishimura syndrome, not provided | Conflicting interpretations of pathogenicity (Feb 1, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr11:111724397
- GRCh38:
- Chr11:111853674
| ALG9 | S255L, S84L, S59L | Gillessen-Kaesbach-Nishimura syndrome, ALG9 congenital disorder of glycosylation, not specified, not provided, ALG9 congenital disorder of glycosylation | Benign/Likely benign (Nov 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:111728332
- GRCh38:
- Chr11:111857609
| ALG9 | A232P, A36P, A61P | Gillessen-Kaesbach-Nishimura syndrome, ALG9 congenital disorder of glycosylation, not provided, ALG9 congenital disorder of glycosylation, See cases | Conflicting interpretations of pathogenicity (Aug 10, 2022) | criteria provided, conflicting interpretations |